Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
9.12
+0.09 (1.00%)
At close: Jul 17, 2026, 4:00 PM EDT
9.00
-0.12 (-1.32%)
After-hours: Jul 17, 2026, 7:31 PM EDT
Turn Therapeutics Market Cap
Turn Therapeutics has a market cap or net worth of $271.67 million as of July 17, 2026.
Market Cap
271.67M
Enterprise Value
266.46M
1-Year Change
n/a
Ranking
Category
Stock Price
$9.12
ChartMarket Cap Chart
Since October 8, 2025, Turn Therapeutics's market cap has increased from $196.16M to $271.67M, an increase of 38.49%. That is a compound annual growth rate of 52.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 271.67M | 134.17% |
| Dec 31, 2025 | 116.01M | -40.86% |
| Oct 8, 2025 | 196.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 289.19M |
| Indaptus Therapeutics | 286.50M |
| MacroGenics | 285.40M |
| ALX Oncology Holdings | 282.58M |
| Galectin Therapeutics | 274.95M |
| InflaRx | 273.23M |
| Sol-Gel Technologies | 271.98M |
| SAB Biotherapeutics | 270.68M |